A detailed history of Panagora Asset Management Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 300,114 shares of RGNX stock, worth $3.23 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
300,114
Previous 222,363 34.97%
Holding current value
$3.23 Million
Previous $3.99 Million 58.43%
% of portfolio
0.03%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$12.17 - $24.61 $946,229 - $1.91 Million
77,751 Added 34.97%
300,114 $6.32 Million
Q4 2023

Feb 08, 2024

BUY
$12.89 - $20.82 $66,821 - $107,930
5,184 Added 2.39%
222,363 $3.99 Million
Q3 2023

Oct 31, 2023

BUY
$16.46 - $19.99 $293,070 - $355,921
17,805 Added 8.93%
217,179 $3.57 Million
Q2 2023

Aug 11, 2023

BUY
$17.23 - $21.71 $1.4 Million - $1.77 Million
81,387 Added 68.98%
199,374 $3.99 Million
Q1 2023

May 11, 2023

BUY
$18.08 - $24.55 $2.13 Million - $2.9 Million
117,987 New
117,987 $2.23 Million
Q2 2022

Aug 15, 2022

SELL
$19.35 - $35.04 $474,674 - $859,566
-24,531 Reduced 20.11%
97,428 $2.41 Million
Q1 2022

May 12, 2022

BUY
$24.62 - $34.31 $116,304 - $162,080
4,724 Added 4.03%
121,959 $4.05 Million
Q4 2021

Feb 10, 2022

BUY
$30.19 - $40.28 $701,283 - $935,664
23,229 Added 24.71%
117,235 $3.83 Million
Q3 2021

Nov 10, 2021

BUY
$29.09 - $45.68 $271,671 - $426,605
9,339 Added 11.03%
94,006 $3.94 Million
Q2 2021

Aug 11, 2021

BUY
$32.46 - $40.48 $1.98 Million - $2.47 Million
61,032 Added 258.23%
84,667 $3.29 Million
Q1 2021

May 12, 2021

BUY
$33.61 - $49.95 $726,345 - $1.08 Million
21,611 Added 1067.74%
23,635 $806,000
Q4 2020

Feb 10, 2021

SELL
$26.52 - $49.35 $1.49 Million - $2.78 Million
-56,265 Reduced 96.53%
2,024 $92,000
Q3 2020

Nov 13, 2020

SELL
$27.01 - $40.26 $1.11 Million - $1.65 Million
-41,050 Reduced 41.32%
58,289 $1.6 Million
Q2 2020

Aug 12, 2020

BUY
$27.75 - $43.44 $1.75 Million - $2.74 Million
63,073 Added 173.92%
99,339 $3.66 Million
Q1 2020

May 14, 2020

SELL
$21.5 - $54.2 $2.31 Million - $5.83 Million
-107,651 Reduced 74.8%
36,266 $1.17 Million
Q4 2019

Feb 12, 2020

BUY
$34.54 - $44.87 $2.72 Million - $3.54 Million
78,868 Added 121.24%
143,917 $5.9 Million
Q3 2019

Nov 12, 2019

BUY
$31.84 - $50.88 $2.07 Million - $3.31 Million
65,049 New
65,049 $2.32 Million
Q2 2019

Aug 09, 2019

SELL
$42.0 - $59.29 $346,458 - $489,083
-8,249 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$39.11 - $75.15 $322,618 - $619,912
8,249 New
8,249 $346,000
Q2 2018

Aug 14, 2018

SELL
$27.2 - $74.35 $33,782 - $92,342
-1,242 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$24.05 - $37.5 $1,010 - $1,575
-42 Reduced 3.27%
1,242 $37,000
Q4 2017

Feb 14, 2018

SELL
$26.0 - $34.6 $453,050 - $602,905
-17,425 Reduced 93.14%
1,284 $43,000
Q3 2017

Nov 14, 2017

BUY
$18.0 - $32.95 $336,762 - $616,461
18,709
18,709 $616,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $465M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.